Fermentalg: 2025 Half-Year Results and Expansion Strategy

Fermentalg, a company specializing in BioSolutions based on aquatic microorganisms, has announced its results for the first half of 2025. Revenue reached €7.6 million, a 20% increase compared to the previous year, mainly due to geographic expansion and the strengthening of its product offering. Operating results remained stable at -€4.4 million despite a challenging economic environment.

Among notable developments, Fermentalg expanded its presence in the North American and Chinese markets and obtained FDA approval for its natural blue colorant. The company focuses on sustainable alternatives to intensive fish oils.

In terms of financing, Fermentalg repaid its convertible bonds this half-year, thus stabilizing its financial structure with €30.3 million in equity and €12.8 million in cash.